Nord/LB Reiterates “Buy” Rating for Fresenius Medical Care AG & Co. (FMS)

Fresenius Medical Care AG & Co. (NYSE:FMS)‘s stock had its “buy” rating reaffirmed by analysts at Nord/LB in a research report issued to clients and investors on Wednesday, December 27th.

Other research analysts also recently issued research reports about the company. Royal Bank of Canada reiterated a “hold” rating and issued a $44.00 price objective on shares of Fresenius Medical Care AG & Co. in a report on Wednesday, September 13th. SunTrust Banks set a $62.00 price target on Fresenius Medical Care AG & Co. and gave the stock a “buy” rating in a research note on Thursday, December 21st. DZ Bank restated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, November 13th. Morgan Stanley downgraded Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a research note on Monday, December 11th. Finally, Zacks Investment Research downgraded Fresenius Medical Care AG & Co. from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $55.67.

Fresenius Medical Care AG & Co. (FMS) opened at $54.64 on Wednesday. Fresenius Medical Care AG & Co. has a 1-year low of $40.02 and a 1-year high of $55.30. The company has a market capitalization of $33,710.00, a PE ratio of 22.49, a PEG ratio of 2.26 and a beta of 0.45. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.22 and a quick ratio of 0.98.

A number of large investors have recently added to or reduced their stakes in FMS. SG Americas Securities LLC grew its stake in Fresenius Medical Care AG & Co. by 205.4% during the 2nd quarter. SG Americas Securities LLC now owns 31,039 shares of the company’s stock worth $1,500,000 after buying an additional 20,875 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Fresenius Medical Care AG & Co. by 3.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 50,834 shares of the company’s stock worth $2,458,000 after acquiring an additional 1,584 shares during the period. Comerica Bank lifted its position in Fresenius Medical Care AG & Co. by 1.1% during the 2nd quarter. Comerica Bank now owns 45,972 shares of the company’s stock worth $2,186,000 after acquiring an additional 497 shares during the period. Blair William & Co. IL lifted its position in Fresenius Medical Care AG & Co. by 2.0% during the 2nd quarter. Blair William & Co. IL now owns 13,638 shares of the company’s stock worth $659,000 after acquiring an additional 264 shares during the period. Finally, BB&T Securities LLC lifted its position in Fresenius Medical Care AG & Co. by 1.4% during the 2nd quarter. BB&T Securities LLC now owns 15,053 shares of the company’s stock worth $727,000 after acquiring an additional 211 shares during the period. Hedge funds and other institutional investors own 3.03% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/12/fresenius-medical-care-fms-receives-buy-rating-from-nordlb.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply